| Citation: | WANG Hanlin, HONG Yuan, TANG Jiaxin, ZHANG Renquan. Study on the expression characteristics, prognostic value, and potential mechanisms of TMEM63C in lung adenocarcinoma[J]. Chinese Journal of General Practice, 2026, 24(4): 559-563. doi: 10.16766/j.cnki.issn.1674-4152.004439 |
| [1] |
BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
| [2] |
黄庭, 贡会源, 唐震, 等. KLHL7在非小细胞肺癌中的表达及其临床意义[J]. 中华全科医学, 2023, 21(7): 1109-1112.
HUANG T, GONG H Y, TANG Z, et al. Expression of KLHL7 in non-small cell lung cancer and its clinical significance[J]. Chinese Journal of General Practice, 2023, 21(7): 1109-1112.
|
| [3] |
SONG Y A, KELAVA L, KISS I. MiRNAs in lung adenocarcinoma: role, diagnosis, prognosis, and therapy[J]. Int J Mol Sci, 2023, 24(17): 13302. DOI: 10.3390/ijms241713302.
|
| [4] |
LIN H R, ZHANG X, FENG Y L, et al. Advancing lung adenocarcinoma prognosis and immunotherapy prediction with a multi-omics consensus machine learning approach[J]. J Cell Mol Med, 2024, 28(13): e18520. DOI: 10.1111/jcmm.18520.
|
| [5] |
KANG H, LEE C J. Transmembrane proteins with unknown function (TMEMs) as ion channels: electrophysiological properties, structure, and pathophysiological roles[J]. Exp Mol Med, 2024, 56(4): 850-860. doi: 10.1038/s12276-024-01206-1
|
| [6] |
HERRERA-QUITERIO G A, ENCARNACIÓN-GUEVARA S. The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer[J]. Front Oncol, 2023, 13: 1244740. DOI: 10.3389/fonc.2023.1244740.
|
| [7] |
SCHMIT K, MICHIELS C. TMEM proteins in cancer: a review[J]. Front Pharmacol, 2018, 9: 1345. DOI: 10.3389/fphar.2018.01345.
|
| [8] |
古联, 梁宝云, 周文君, 等. 跨膜蛋白63C基因遗传多态性与缺血性脑卒中气虚证显著关联[J]. 中国老年学杂志, 2023, 43(1): 15-20.
GU L, LIANG B Y, ZHOU W J, et al. Transmembrane protein 63C gene polymorphism significantly associated with Qi deficiency syndrome of ischemic stroke[J]. Chinese Journal of Gerontology, 2023, 43(1): 15-20.
|
| [9] |
朱明雪, 闫清, 王鹏, 等. EGFR突变对肺腺癌预后及治疗意义生物信息分析[J]. 青岛大学学报(医学版), 2023, 59(4): 522-526.
ZHU M X, YAN Q, WANG P, et al. Significance of epidermal growth factor receptor mutation in the prognosis and treatment of lung adenocarcinoma: a bioinformatics analysis[J]. Journal of Qingdao University(Medical Sciences), 2023, 59(4): 522-526.
|
| [10] |
TÁBARA L C, AL-SALMI F, MAROOFIAN R, et al. TMEM63C mutations cause mitochondrial morphology defects and underlie hereditary spastic paraplegia[J]. Brain, 2022, 145(9): 3095-3107. doi: 10.1093/brain/awac123
|
| [11] |
DE VISSER K E, JOYCE J A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth[J]. Cancer Cell, 2023, 41(3): 374-403.
|
| [12] |
MYERS J A, MILLER J S. Exploring the NK cell platform for cancer immunotherapy[J]. Nat Rev Clin Oncol, 2021, 18(2): 85-100. doi: 10.1038/s41571-020-0426-7
|
| [13] |
DEL PRETE A, SALVI V, SORIANI A, et al. Dendritic cell subsets in cancer immunity and tumor antigen sensing[J]. Cell Mol Immunol, 2023, 20(5): 432-447.
|
| [14] |
PLESCA I, MVLLER L, BÖTCHER J P, et al. Tumor-associated human dendritic cell subsets: phenotype, functional orientation, and clinical relevance[J]. Eur J Immunol, 2022, 52(11): 1750-1758. doi: 10.1002/eji.202149487
|
| [15] |
XIONG S M, DONG L L, CHENG L. Neutrophils in cancer carcinogenesis and metastasis[J]. J Hematol Oncol, 2021, 14(1): 173. doi: 10.1186/s13045-021-01187-y
|
| [16] |
HE Y, SUN M M, ZHANG G G, et al. Targeting PI3K/Akt signal transduction for cancer therapy[J]. Signal Transduct Target Ther, 2021, 6(1): 425.
|